Literature DB >> 6277447

Hepatocellular carcinoma arising in noncirrhotic and highly cirrhotic livers: a comparative study of histopathology and frequency of hepatitis B markers.

K Okuda, T Nakashima, K Sakamoto, T Ikari, H Hidaka, Y Kubo, K Sakuma, Y Motoike, H Okuda, H Obata.   

Abstract

Hepatocellular carcinoma (HCC) associated with cirrhosis and HCC developing in a noncirrhotic liver may have differing pathogeneses. To study this possibility, 425 autopsied cases of HCC were investigated. Of these, 45 livers were not cirrhotic, 50 were highly cirrhotic (liver weight less than 99 g), and the remaining 331 were cirrhotic but not so highly. The average age was significantly older in the highly cirrhotic group, suggesting a longer premalignant period of chronic liver disease. The liver weight in the noncirrhotic group was about 3.5 times that in the highly cirrhotic group. Hepatitis B surface antigen was positive in serum in only 9.3% and in liver tissue in 10% in the noncirrhotic cases, the positivity rate being much lower compared with other groups (P less than 0.005--0.01), yet antibody to HB core was positive in 90%. The antibody titers were low, however, indicating that these noncirrhotic patients had in the past had HB virus (HBV) infection with no residual chronic B hepatitis. Analysis of the grades of anaplasia of cancer tissue demonstrated an inverse correlation between the degree of fibrosis and grade of anaplasia, i.e., the more advanced the fibrosis, the less anaplastic the cancer. These data suggest that HCC arising in highly cirrhotic liver and in noncirrhotic livers have different pathogenetic backgrounds, and that HBV infection, even though transient, has a certain role in hepatocarcinogenesis. The generally held conjecture that HCC in a noncirrhotic liver is caused by nonviral carcinogens and HCC arising on the ground of cirrhosis is due to HBV seems untenable in such a simple concept.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6277447     DOI: 10.1002/1097-0142(19820201)49:3<450::aid-cncr2820490310>3.0.co;2-4

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  16 in total

1.  Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults.

Authors:  S D Ryder
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

Review 2.  Hepatocellular carcinoma. A worldwide problem and the major risk factors.

Authors:  R G Simonetti; C Cammà; F Fiorello; F Politi; G D'Amico; L Pagliaro
Journal:  Dig Dis Sci       Date:  1991-07       Impact factor: 3.199

Review 3.  The role of cirrhosis in the etiology of hepatocellular carcinoma.

Authors:  Michael C Kew
Journal:  J Gastrointest Cancer       Date:  2014-03

4.  Fibrosis in non-cancerous tissue is the unique prognostic factor for primary hepatocellular carcinoma without hepatitis B or C viral infection.

Authors:  Yoshito Tomimaru; Yo Sasaki; Terumasa Yamada; Hidetoshi Eguchi; Hiroaki Ohigashi; Osamu Ishikawa; Shingi Imaoka
Journal:  World J Surg       Date:  2006-09       Impact factor: 3.352

5.  The epidemiology of primary liver cancer in a West German population: the Saarland.

Authors:  K Rimkus; G Dhom
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

6.  Diabetes: one of few remarkable differences in clinicopathologic features between cirrhotic and noncirrhotic Swedes with hepatocellular carcinoma.

Authors:  Jerzy Kaczynski; Göran Hansson; Sven Wallerstedt
Journal:  Dig Dis Sci       Date:  2006-04       Impact factor: 3.199

7.  High prevalence of hepatitis B and C viral markers in Japanese patients with hepatocellular carcinoma.

Authors:  N Tanaka; T Chiba; Y Matsuzaki; T Osuga; T Aikawa; K Mitamura
Journal:  Gastroenterol Jpn       Date:  1993-08

8.  Hepatocellular carcinoma with or without cirrhosis: a comparison of CT and angiographic presentations in the United States and Japan.

Authors:  Y Yamashita; M Takahashi; Y Baba; S Kanazawa; C Charnsangavej; D Yang; S Wallace
Journal:  Abdom Imaging       Date:  1993

9.  Chemoembolization of intermediate stage hepatocellular carcinomas: results from a Nordic tertiary liver cancer center.

Authors:  Kasper J Andersen; Henning Grønbaek; Gerda Elisabeth Villadsen; Anders Riegels Knudsen; Peter Ott; Hendrik Vildstrup; Dennis Tønner Nielsen; Arindam Bharadwaz
Journal:  Indian J Gastroenterol       Date:  2013-12-04

10.  Impaired liver function and long-term prognosis after hepatectomy for hepatocellular carcinoma.

Authors:  M Yasui; A Harada; A Torii; A Nakao; T Nonami; H Takagi
Journal:  World J Surg       Date:  1995 May-Jun       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.